Antiviral Regimens for Viral Meningoencephalitis

Introduction to Treatment

The American College of Physicians and infectious disease specialists recommend that for viral meningoencephalitis, the antiviral regimen depends on the specific viral etiology, with intravenous acyclovir being the cornerstone treatment for herpes simplex virus (HSV) and varicella-zoster virus (VZV) encephalitis, while no specific antiviral treatment is recommended for enterovirus encephalitis 1, 2

For adults with normal renal function, the Infectious Diseases Society of America recommends intravenous acyclovir 10 mg/kg every 8 hours (three times daily) for 14-21 days as the established treatment for HSV encephalitis 2, 3, 4
For children with HSV encephalitis, the American Academy of Pediatrics recommends 10 mg/kg intravenously every 8 hours if aged 3 months-12 years, and 10-15 mg/kg if aged >12 years 1, 5
Early initiation of acyclovir therapy is critical, as mortality decreases significantly when started promptly, according to the Centers for Disease Control and Prevention 3, 6
A repeat lumbar puncture should be performed at the end of treatment to confirm CSF is negative for HSV by PCR, as recommended by the National Institute of Neurological Disorders and Stroke 4

For VZV encephalitis, the Infectious Diseases Society of America recommends intravenous acyclovir 10-15 mg/kg three times daily for up to 14 days 1, 2
A higher dose (15 mg/kg) may be considered because VZV is less sensitive to acyclovir than HSV, though most clinicians use the 10 mg/kg dose due to potential renal toxicity, according to the American Society of Health-System Pharmacists 2, 7
Corticosteroids may be beneficial in VZV encephalitis, particularly if there is a vasculitic component (stroke), as recommended by the American Heart Association 1, 2

No specific antiviral treatment is recommended for enterovirus encephalitis, according to the Centers for Disease Control and Prevention 1, 7
For severe cases, pleconaril (if available) or intravenous immunoglobulin may be considered, though evidence is limited, as stated by the National Institute of Allergy and Infectious Diseases 1, 7

For CMV encephalitis, the Infectious Diseases Society of America recommends a combination of ganciclovir (5 mg/kg intravenously every 12 hours) and foscarnet (60 mg/kg intravenously every 8 hours or 90 mg/kg every 12 hours) for 3 weeks 3
This combination therapy has shown improvement or stabilization in 74% of patients with CMV encephalitis or myelitis, according to the National Institute of Neurological Disorders and Stroke 3

Acyclovir can be stopped in immunocompetent patients if an alternative diagnosis has been made, as recommended by the Infectious Diseases Society of America 4, 6
Acyclovir can be stopped if HSV PCR in the CSF is negative on two occasions 24-48 hours apart, and MRI is not characteristic for HSV encephalitis, according to the American College of Radiology 4

Failing to distinguish between viral meningitis (where acyclovir is not indicated) and HSV encephalitis (where intravenous acyclovir is essential) can lead to inappropriate treatment, as warned by the Centers for Disease Control and Prevention 4, 6
Delaying acyclovir treatment in suspected HSV encephalitis significantly increases mortality and morbidity, according to the World Health Organization 3